Assessment of Factors Limiting Advanced Technology Adoption in Maize Cultivation in Uganda: A Case Study of Kabale District South Western Uganda. by Asiimwe, Moses

Subjects: Get full text

Alloplasmic recombinant lines (H. vulgare)-T. aestivum with 1RS.1BL translocation: initial genotypes for production of common wheat varieties by L. A. Pershina, L. I. Belova, N. V. Trubacheeva, T. S. Osadсhaya, V. K. Shumny, I. A. Belan, L. P. Rosseeva, V. V. Nemchenko, S. N. Abakumov

Subjects: Get full text

FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management by Muhammad Mazhar Azam, Sameen Mukhtar, Muhammad Haris, Fatima Laique, Suhaina Amir, Mubashir Mohiuddin, Bibek Giri

Subjects: Get full text

On Feller's criterion for the law of the iterated logarithm by Deli Li, M. Bhaskara Rao, Xiangchen Wang

Subjects: “…central limit theorem…”
Get full text

Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program) by M. V. Mayevskaya, V. T. Ivashkin, V. D. Lunkov, S. P. Kryzhanovskiy, I. Yu. Pirogova, Ch. S. Pavlov, M. S. Zharkova, A. G. Beniashvili, M. A. Morozova

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Liver macrophage activation: Relation with hepatic histopathological changes in patients with metabolic associated steatotic liver disease by Doaa H. Hegazy, Fathalla S. Mohamed, Sabah A. H. Mahmoud, Nevine M. F. El Deeb, Amany Elyamany, Ahmed M. Elgendi

Subjects: “…metabolic associated steatotic liver disease…”
Get full text

The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease by Anna E. Płatek, Julia A. Szymańska

Subjects: “…metabolic dysfunction-associated steatotic liver disease…”
Get full text

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion by V. V. Tsukanov, M. F. Osipenko, E. V. Beloborodova, M. A. Livzan, I. B. Khlynov, S. A. Alekseenko, Yu. P. Sivolap, J. L. Tonkikh, A. V. Vasyutin

Subjects: “…alcoholic liver disease (ald)…”
Get full text

MDTR: a knowledge-guided interpretable representation for quantifying liver toxicity at transcriptomic level by Inyoung Sung, Sangseon Lee, Dongmin Bang, Dongmin Bang, Jungseob Yi, Sunho Lee, Sun Kim, Sun Kim, Sun Kim, Sun Kim

Subjects: “…drug-induced liver injury…”
Get full text

Correlation between liver fibrosis in non-alcoholic fatty liver disease and insulin resistance indicators: a cross-sectional study from NHANES 2017–2020 by Bo Yang, Mingsu Gong, Xiaojie Zhu, Yang Luo, Ruiqiu Li, Hai Meng, Yuhan Wang

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease by Mi Zhou, Jianyu Lv, Xinli Chen, Yujie Shi, Guanqun Chao, Shuo Zhang

Subjects: Get full text

Helicobacter pylori Infection and Hepatobiliary Pathology by S. V. German, I. P. Bobrovnitsky

Subjects: Get full text

Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease by V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

A randomized double-blind clinical trial investigating the effects of ellagic acid on glycemic status, liver enzymes, and oxidative stress in patients with non-alcoholic fatty liver disease by Sara Mighani, Rasoul Samimi, Mohamadreza Rashidi Nooshabadi, Seyed Amir Farzam, Hossein Khadem Haghighian, Maryam Javadi

Subjects: Get full text

The fibrosis-4 index and its association with carotid atherosclerosis in type 2 diabetes: a cross-sectional study in China by Ying Miao, Yu Wang, Qin Wan, Nanwei Tong

Subjects: Get full text

Clostridium Scindens Protects Against Vancomycin‐Induced Cholestasis and Liver Fibrosis by Activating Intestinal FXR‐FGF15/19 Signaling by Jintao Xiao, Yanliang Hou, Xingyang Luo, Yuhao Zhu, Wenhu Li, Bingbing Li, LinXiang Zhou, Xia Chen, Ying Guo, Xiaomei Zhang, Haiyue He, Xiaowei Liu

Subjects: “…cholestatic liver diseases…”
Get full text

Elevated Liver Function Tests as Predictors of Severe Maternal Outcomes in Women with Preeclampsia by Sadia Chaudhary, Hafiza Ateeqa Mubarak, Anila Sabir, Hina Sadaf, Anas Khalil, Zahid Mahmood, Marium Shoukat, Farah Naz Tahir

Subjects: Get full text

« Ils ont transformé la divinité Yuma en Dieu ! » by Mélanie Vandenhelsken

Subjects: Get full text

Commonly available dietary supplements, herbs and medicines – do they pose a risk for liver health? Literature review in the context of the Polish population by Ewa Janczewska, Barbara Janota

Subjects: “…liver…”
Get full text

Uric acid as a potential marker of cardiometabolic risk in children and adolescents with metabolic dysfunction associated steatotic liver disease by Katarzyna Zdanowicz, Natalia Kopiczko, Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Monika Kowalczuk-Kryston, Dariusz Lebensztejn

Subjects: Get full text